Normal C57BL/6 mice were inoculated with MC-38 SC in the right hindflank (Table 1, experiment 3). Two courses of treatment were given as indicated. Cures were achieved in 30% of mice receiving Cy + L-IL-2 therapy, while 90% of mice receiving CD4-based therapy were free of tumor.